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1. INTRODUCTION {#jcmm14686-sec-0001}
===============

Acute colitis is characterized by infiltration of inflammatory cells into the mucosa, leading to submucosal congestion and oedema,[1](#jcmm14686-bib-0001){ref-type="ref"} and the inflammation cells may involve the whole colon or be limited to colonic segments.[1](#jcmm14686-bib-0001){ref-type="ref"} The main symptoms of acute colitis include acute pain, vomiting, weight loss, diarrhoea and bloody stool,[2](#jcmm14686-bib-0002){ref-type="ref"} and its incidence and prevalence are being increasing in developing and developed countries.[3](#jcmm14686-bib-0003){ref-type="ref"}, [4](#jcmm14686-bib-0004){ref-type="ref"} Quinolones and probiotics are commonly used to improve the acute colitis; however, the options for medical management and colitis treatment are limited. Therefore, discovery of cost‐effective and efficacious agents for colitis is necessary.

Taraxacum officinale (TO), a herbaceous perennial plant of the family Asteraceae, is widely used as an herbal remedy in Asia, Europe and North America. The therapeutic value of TO was mentioned in acute mastitis in 659 A. D in China, and it was used to cure liver and spleen ailments by the Arabian physicians during the 10th and 11th centuries. Accumulating evidence indicates that taraxacum officinale extract (TOE) exhibits various biological activities, such as anti‐inflammatory,[5](#jcmm14686-bib-0005){ref-type="ref"}, [6](#jcmm14686-bib-0006){ref-type="ref"} antioxidant [7](#jcmm14686-bib-0007){ref-type="ref"}, [8](#jcmm14686-bib-0008){ref-type="ref"} and antifibrotic activities,[9](#jcmm14686-bib-0009){ref-type="ref"}, [10](#jcmm14686-bib-0010){ref-type="ref"} and possess the properties against type 2 diabetes,[11](#jcmm14686-bib-0011){ref-type="ref"} non‐alcoholic fatty liver disease (NAFLD),[12](#jcmm14686-bib-0012){ref-type="ref"}, [13](#jcmm14686-bib-0013){ref-type="ref"} obesity [14](#jcmm14686-bib-0014){ref-type="ref"} and cancers.[15](#jcmm14686-bib-0015){ref-type="ref"}, [16](#jcmm14686-bib-0016){ref-type="ref"} However, there is little knowledge about the effects of TOE on acute colitis.

Chemistry‐induced experimental colitis models are widely applied owing to the fast onset of inflammation and relatively simple operation procedures.[17](#jcmm14686-bib-0017){ref-type="ref"}, [18](#jcmm14686-bib-0018){ref-type="ref"} Dextran sulphate sodium (DSS) is used to induce severe colitis in mice, characterized by weight loss, bloody diarrhoea, ulcer formation, loss of epithelial cells and infiltrations with neutrophils,[19](#jcmm14686-bib-0019){ref-type="ref"} which is associated with DSS‐caused toxicity towards gut epithelial cells and the integrity of mucosal barrier.[20](#jcmm14686-bib-0020){ref-type="ref"} Moreover, DSS tends to decrease intestinal microbial community evenness [21](#jcmm14686-bib-0021){ref-type="ref"} and enhances mucosal CD4^+^ T responses, involved in the pathogenesis of acute colitis.[22](#jcmm14686-bib-0022){ref-type="ref"}

In the present study, we assessed the effects of TOE on DSS‐induced colitis in mice and found that TOE attenuated DSS‐induced colitis by regulating fatty acid degradation, cytokine‐receptor signalling and microbial dysbiosis. Our findings might provide a novel strategy for the treatment of acute colitis.

2. METHODS AND MATERIALS {#jcmm14686-sec-0002}
========================

2.1. Experimental Animals {#jcmm14686-sec-0003}
-------------------------

Male C57BL/6 mice, 6‐8 weeks old and weighing 18 ± 2 g were provided by West Pui Kai experimental animal Co., Ltd and fed in SPF standard laboratory conditions at animal laboratory centre of our hospital. The animal study was approved by the ethics committee of Shanghai Sixth People\'s Hospital (No: 2018‐0080).

2.2. DSS‐induced colitis and TOE treatment {#jcmm14686-sec-0004}
------------------------------------------

According to the previous report,[23](#jcmm14686-bib-0023){ref-type="ref"} acute experimental colitis was induced by drinking 3% (wt/vol) DSS (36‐50 kD, MP Biomedicals) for a week and then was treated by the low‐dose TOE (TOEL, 0.9 g/kg/d) or high‐dose TOE (TOEH, 1.8 g/kg/d) for 8 days. The mice were classified into control group (distilled water), DSS group, TOEL and TOEH groups.

2.3. Tissue collection {#jcmm14686-sec-0005}
----------------------

After the mice were sacrificed, the colon tissues were collected. The length of each colon was recorded, and each colon was washed in PBS. Then, 0.5 cm colon segments near the anus were used for RNA extraction and 1.0 cm were fixed in 4% formaldehyde for histological analysis. The remaining tissues were rapidly frozen in liquid nitrogen at −80°C.

2.4. Clinical scoring of murine colitis {#jcmm14686-sec-0006}
---------------------------------------

According to the criteria described by Stefan Wirtz,[23](#jcmm14686-bib-0023){ref-type="ref"} the mice in each group was observed daily in the morning, and the weight loss, stool consistency and the degree of intestinal bleeding were recorded. Criteria for the different scores are shown in Table [S1](#jcmm14686-sup-0004){ref-type="supplementary-material"}. A disease activity index (DAI) was calculated based on the sum of the scores for bodyweight loss, diarrhoea and bleeding.

2.5. Haematoxylin and eosin (H&E) staining {#jcmm14686-sec-0007}
------------------------------------------

The colon tissues were isolated from the mice in each group and fixed on a 4% paraformaldehyde solution for 48 hours and embedded in paraffin. Histological examinations were performed by H&E staining. According to the previous studies,[23](#jcmm14686-bib-0023){ref-type="ref"}, [24](#jcmm14686-bib-0024){ref-type="ref"} the pathological scoring was conducted.

2.6. Real‐time PCR (RT‐PCR) {#jcmm14686-sec-0008}
---------------------------

According to the instructions, total RNA was isolated from colon tissues using the Trizol reagent (Invitrogen). Complementary DNA (cDNA) is produced by RNA reverse transcription by using the PrimeScript™ Reverse Transcription Kit (TakaRa). The procedures were performed as follow: Stage 1:Pre‐denaturation at 95°C for 30 seconds, 1 cycle; Stage 2: PCR, at 95°C for 5 seconds and 60°C for 34 seconds, 40 cycles; and Stage 3: at 95°C for 30 seconds and 60°C for 1 minute, 1 cycle. The gene expression levels were calculated using the 2^−ΔΔCt^ method. Glyceraldehyde 3‐phosphate dehydrogenase (GAPDH) was used as the internal control. All qPCR reactions were performed in duplicate. The primers used in this study were listed in Table [1](#jcmm14686-tbl-0001){ref-type="table"}.

###### 

List of the gene primers

  Gene      Forward primer             Reverse primer
  --------- -------------------------- ---------------------------
  GAPDH     CCTCGTCCCGTAGACAAAATG      TGAGGTCAATGAAGGGGTCGT
  TNF‐α     CCCTCACACTCACAAACCACC      CTTTGAGATCCATGCCGTTG
  IL‐6      GAAATGATGGATGCTACCAAACTG   GACTCTGGCTTTGTCTTTCTTGTT
  IL‐1β     CACTACAGGCTCCGAGATGAAC     TCCATCTTCTTCTTTGGGTATTGC
  IFN‐γ     AGCAACAACATAAGCGTCAT       CCTCAAACTTGGCAATACTC
  CCL20     CAGGCAGAAGCAAGCAACTACG     TGACTCTTAGGCTGAGGAGGTTC
  CXCL5     GCGTTGTGTTTGCTTAACCGT      AGCTTTCTTTTTGTCACTGCCC
  CD40      ACCCATGTGACTCAGGCGAAT      TGGTGCAGTGTTGTCCTTCC
  CXCL1     CTGCACCCAAACCGAAGTCAT      TGGGGACACCTTTTAGCATCT
  CCR6      CCTCCTGGGCAACATTATGGT      GCATCGCTGAAAACCCAAGTG
  Adh5      ACAGATGGGGGCGTGGATTA       GCCTTTCCATGTGCGTCCT
  Acox3     GACGCATCTCCATCATCAGCAT     GCCAGAGCATGGATCTCACGT
  Tnfsf11   CCATCGGGTTCCCATAAAGTCA     CAGTTTTTCGTGCTCCCTCCTT
  CXCL13    GGCCACGGTATTCTGGAAGC       TTGGCACGAGGATTCACACA
  Tnfrsf8   CGGGAACTCTCCTCGAATCTGT     ATGGCCTGAGGAGTGGCAT
  Aldh3a2   GCGAAGCCTCCCTCCAGAAT       CCTCATCCATCTCTCCACCGAA
  CCL6      AGAAGATCGTCGCTATAACCCTC    TAGGCACCTCTGAACTCTCCG
  CCl28     CTCACCTGAGTCATTGCCAGA      CATGGGAAGTATGGCTTCTGAG
  CCL5      TGCCCACGTCAAGGAGTATTT      GATGTATTCTTGAACCCACTTCTTC
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2.7. Immunohistochemistry (IHC) {#jcmm14686-sec-0009}
-------------------------------

To assess the severity of DSS‐induced colitis, the intensity of inflammation and other markers related to fatty acid degradation and cytokines were determined by using IHC analysis. The colon tissues were immune‐stained for anti‐TNF alpha (17590‐1‐ap; Proteintech), anti‐IL‐6 (21865‐1‐AP, Proteintech), anti‐IL‐1β (ab33591, Lianke Biotechnology), anti‐ACOX3 (NBP1‐85901, Novus Biologicals), anti‐ALDH3A2 (15090‐1‐AP, Proteintech), anti‐CXCL5 (ab9802, Abcam), anti‐GRO alpha ( also termed as anti‐CXCL1, ab86436, Abcam), anti‐MIP3a ( also termed as anti‐CCL20, ab136904, Abcam) and anti‐ADH5 (ab177932, Abcam) as previously described.[25](#jcmm14686-bib-0025){ref-type="ref"}

2.8. Transcriptome sequencing analysis {#jcmm14686-sec-0010}
--------------------------------------

Total RNA was isolated from the colon tissues of the control, DSS, TOEL and TOEH groups and then was detected by agarose gel electrophoresis. NanoDrop ND‐1000 was used for further quality control of total RNA. A total of 1‐2 μg RNA from each sample was used as input material for generation of the RNA library. Following cluster generation, the libraries were sequenced on an Illumina Hiseq 4000 platform. After the transcriptome sequencing, the raw data were subjected to the KEGG and GSEA analysis.

2.9. 16S rDNA sequencing {#jcmm14686-sec-0011}
------------------------

Bacterial genomic DNA was extracted from stool samples in each group. The 16S rDNA V4 region was amplified by PCR using barcoded Illumina adapter‐containing 515F and 806R primers. Qubit 3.0 was used to quantify each sample, and pooling of equal quality was used as a library to ensure the homogeneity of samples. After the library was qualified, illumina high‐throughput sequencing platform (HiSeq/MiniSeq) was used for 16S rDNA sequencing.

2.10. Statistical analysis {#jcmm14686-sec-0012}
--------------------------

Statistical analyses were conducted by SPSS 17.0 (IBM, SPSS) and GraphPad Prism. Data are expressed as mean ± SD. Analysis of Variance (ANOVA) was used to analyse the difference between four groups, and independent *t* test was used to analyse the significance of two groups. *P* \< .05 was considered statistically significant.

3. RESULTS {#jcmm14686-sec-0013}
==========

3.1. TOE attenuated the severity of clinical symptoms and inflammatory infiltration in DSS‐induced colitis {#jcmm14686-sec-0014}
----------------------------------------------------------------------------------------------------------

To determine the effects of TOE on acute colitis, we established a DSS‐induced acute colitis model. Representative schematic of the mice in four groups was demonstrated in Figure [1](#jcmm14686-fig-0001){ref-type="fig"}A. The bodyweight was dramatically decreased by DSS as compared with the control group, and this result could be reversed by TOEH and TOEL (Figure [1](#jcmm14686-fig-0001){ref-type="fig"}B). Likewise, an increased cumulative DAI was increased by DSS as compared with the control group, but this effect was reversed by the TOEH and TOEL (Figure [1](#jcmm14686-fig-0001){ref-type="fig"}C). Representative schematic of the colon tissues in four groups was indicated in Figure [1](#jcmm14686-fig-0001){ref-type="fig"}D and the shortened colon length was caused by DSS as compared with the control group, but this effect was reversed by TOEH rather than TOEL (Figure [1](#jcmm14686-fig-0001){ref-type="fig"}E). Additionally, HE staining revealed that DSS induced an obvious inflammatory response, characterized by neutrophil infiltration, crypt loss, submucosal oedema and goblet cell loss, but TOEH and TOEL reduced these inflammatory responses (Figure [1](#jcmm14686-fig-0001){ref-type="fig"}F). Histopathological scores were substantially increased in DSS group as compared with the control group, but these results were reversed by TOEH rather than TOEL (Figure [1](#jcmm14686-fig-0001){ref-type="fig"}G).

![TOE attenuated the severity of clinical symptoms and inflammatory infiltration in DSS‐induced colitis. A, Representative schematic of the mice in control, DSS, TOEL and TOEH groups. B, Comparison of the mean bodyweight in these four groups (\**P* \< .05, DSS vs TOEH; \*\**P* \< .01, DSS vs TOEL). C, Comparison of the alterations in disease activity index (DAI; \*\*\**P* \< .001, DSS vs TOEH or TOEL). D. Representative schematic of the colon samples in control, DSS, TOEL and TOEH groups. E. Comparison of the mean colon lengths (\*\*\**P* \< .001, control vs DSS; \**P* \< .05, DSS vs TOEH). F, H&E analysis of the histopathological scoring in colon tissue samples from these four groups (4×, 10×, 20×, 40×). G, Comparison of the histopathological scores in colon tissue samples from these four groups. (\*\*\**P* \< .001, control vs DSS; \**P* \< .05, DSS vs TOEH)](JCMM-23-8161-g001){#jcmm14686-fig-0001}

3.2. TOE diminished the production of pro‐inflammatory cytokines in DSS‐induced colitis {#jcmm14686-sec-0015}
---------------------------------------------------------------------------------------

The pro‐inflammatory cytokines act a critical role in the pathogenesis of acute colitis, and the levels of pro‐inflammatory cytokines are reported increased in DSS‐induced colitis.[26](#jcmm14686-bib-0026){ref-type="ref"} To determine whether TOE exerts anti‐inflammatory effects in DSS‐induced colitis, we examined the expression levels of pro‐inflammatory cytokines TNF‐α, IL‐6, IFN‐γ and IL‐1β in colon tissues by RT‐PCR (Figure [2](#jcmm14686-fig-0002){ref-type="fig"}A) and IHC analysis (Figure [2](#jcmm14686-fig-0002){ref-type="fig"}B), which showed that their expression levels were notably elevated by DSS as compared with the control group, but these effects were reversed by TOEH and (or) TOEL.

![TOE reduced the production of inflammatory cytokines in DSS‐induced colitis. A, B, RT‐PCR and IHC analysis of the expression levels of inflammatory cytokines TNF‐*α*, IL‐6, IL‐1*β*and IFN**‐*γ*** in colon tissue samples from these four samples*.* \**P* \< .05, \*\**P* \< .01, \*\*\**P* \< .001](JCMM-23-8161-g002){#jcmm14686-fig-0002}

3.3. TOE promoted the fatty acid degradation in DSS‐induced colitis {#jcmm14686-sec-0016}
-------------------------------------------------------------------

To understand the underlying mechanisms by which TOE attenuated DSS‐induced colitis, we performed a transcriptome sequencing using the colon tissues between the control, DSS, TOEL and TOEH groups. Based on the fold change, the differentially expressed genes were identified by thermogram and volcano map between control, DSS and TOEH groups (Figure [S1](#jcmm14686-sup-0001){ref-type="supplementary-material"}A,B and Figure [3](#jcmm14686-fig-0003){ref-type="fig"}A,B), of which 499 up‐regulated genes and 367 down‐regulated genes were identified between DSS and TOEH groups (Figure [3](#jcmm14686-fig-0003){ref-type="fig"}A,B). KEGG and GSEA analysis unveiled that fatty acid degradation, a key fat metabolic pathway, was indicated to be enriched in TOEH treatment group as compared with the DSS group (Figure [S1](#jcmm14686-sup-0001){ref-type="supplementary-material"}C,D and Figure [4](#jcmm14686-fig-0004){ref-type="fig"}A). Five major genes in fatty acid degradation were shown to be induced by TOEH, of which Aldh3a2, Acox3 and Adh5 displayed the significantly increased expression in TOEH group as compared with the DSS group (Figure [4](#jcmm14686-fig-0004){ref-type="fig"}B). Further RT‐PCR (Figure [4](#jcmm14686-fig-0004){ref-type="fig"}C) and IHC analysis (Figure [4](#jcmm14686-fig-0004){ref-type="fig"}D) confirmed that the expression levels of Aldh3a2, Acox3 and Adh5 were lowered by DSS as compared with the control group, but were increased by TOEH and (or) TOEL as compared with the DSS group.

![The differentially expressed genes were identified between DSS and TOEH groups by transcriptome sequencing. A, Hierarchical clustering analysis was performed to establish the gene expression profiling between these two groups. B, Volcano plotting of the differentially expressed genes between DSS and TOEH groups. Red colours indicated the up‐regulated genes and blue colours indicated the down‐regulated genes. C, The genes that were most significantly differentially expressed were analysed by KEGG enrichment analysis](JCMM-23-8161-g003){#jcmm14686-fig-0003}

![TOE promoted the fatty acid degradation in DSS‐induced colitis. A, B, GSEA identification of the five major genes in fatty acid degradation in TOEH group as compared with the DSS group. C, D, RT‐PCR and IHC analysis of the expression levels of Aldh3a2, Acox3 and Adh5 in TOEH and DSS groups. \**P* \< .05, \*\**P* \< .01, \*\*\**P* \< .001](JCMM-23-8161-g004){#jcmm14686-fig-0004}

3.4. TOE inhibited the cytokine‐receptor signalling in DSS‐induced colitis {#jcmm14686-sec-0017}
--------------------------------------------------------------------------

Further GSEA analysis showed that the cytokine‐receptor signalling was involved in TOEH‐treated colitis as compared with the DSS group (Figure [5](#jcmm14686-fig-0005){ref-type="fig"}A), and 11 genes in this signalling were identified to be down‐regulated in TOEH treatment group, of which 11 genes (CCL20, CCL28, CXCL5, CCR6, CXCL1, CXCL13, CCL6, CCL5, CD40, Tnfsf11 and Tnfrsf8) had the markedly decreased expression in TOEH group as compared with the DSS group (Figure [5](#jcmm14686-fig-0005){ref-type="fig"}B). RT‐PCR (Figure [5](#jcmm14686-fig-0005){ref-type="fig"}C) and IHC analysis (Figure [5](#jcmm14686-fig-0005){ref-type="fig"}D) verified that the expression levels of CCL28, CCL6, CCL5, CXCL5, CCR6, CXCL1, CD40, Tnfsf11 and Tnfrsf8 were increased by DSS as compared with the control group (Figure [5](#jcmm14686-fig-0005){ref-type="fig"}C,D and Figure [S2](#jcmm14686-sup-0002){ref-type="supplementary-material"}), but TOEH and (or) TOEL counteracted DSS‐induced CCL20, CXCL5, CCR6, CXCL1 and CXCL13 expression in colon tissues (Figure [5](#jcmm14686-fig-0005){ref-type="fig"}C,D and Figure [S2](#jcmm14686-sup-0002){ref-type="supplementary-material"}).

![TOE inhibited the cytokine‐receptor signalling in DSS‐induced colitis. A, B, GSEA identification of the 11 major genes in cytokine‐receptor signalling in TOEH group as compared with the DSS group. C, D, RT‐PCR and IHC analysis of the expression levels of CCL20, CXCL5, CCR6 and CXCL1 in TOEH and DSS groups. \**P* \< .05, \*\**P* \< .01, \*\*\**P* \< .001](JCMM-23-8161-g005){#jcmm14686-fig-0005}

3.5. TOE regulated the gut microbial dysbiosis in DSS‐induced colitis {#jcmm14686-sec-0018}
---------------------------------------------------------------------

Gut microbiota is associated with the acute colitis [21](#jcmm14686-bib-0021){ref-type="ref"}, and whether TOE modifies the gut microbiota in DSS‐induced colitis was further assessed using the colon stool samples and 16S rDNA sequencing between the four groups. The alpha diversity of microbial communities, as indicated by the Observe, Chao1, ACE, Shannon, Simpson and J index, tended to increase in DSS‐induced colitis, but was decreased by TOEH (Figure [6](#jcmm14686-fig-0006){ref-type="fig"}A). In addition, beta diversity had a significant difference between DDS and TOEH groups based on the weighted PCoA (Figure [6](#jcmm14686-fig-0006){ref-type="fig"}B). Moreover, the genus abundant levels showed that *Clostridiale, S24‐7, Lanchnospiraceae, Enterobacteriaceae, Ruminococcaceae* and *Oscillospira* had a significant difference between DSS and TOEH groups (Figure [6](#jcmm14686-fig-0006){ref-type="fig"}C). The thermograms showed that the top 30 microflora were found between DSS and TOEH groups (Figure [6](#jcmm14686-fig-0006){ref-type="fig"}D). As shown in Figure [6](#jcmm14686-fig-0006){ref-type="fig"}E, the enrichment levels of these six bacteria displayed a statistical difference, of which the amount of *anaerostipes, enterococcus, peptostreptococcaceae* and *enterobacteriaceae* was lowered in TOEH group, but that of *S24‐7 and adlercreutzia* was elevated as compared with that in DSS group. The alpha and beta diversity, and the genus abundant levels between DSS and Control groups were indicated in Figure [S3](#jcmm14686-sup-0003){ref-type="supplementary-material"}.

![TOE regulated the gut microbial dysbiosis in DSS‐induced colitis. A, Alpha diversity was estimated by the Observe, Chao1, ACE, Shannon, Simpson and J index in DSS and TOEH groups. B, Beta diversity was assessed by the weighted PCoA in DSS and TOEH groups. C, Comparison of the difference in genus levels of gut microbiota between DSS and TOEH groups. D, The heat maps of the top 30 gut microbiota species in DSS and TOEH groups. E, Bar plots showed the relative abundance in genus levels in DSS and TOEH groups. \**P* \< .05, \*\**P* \< .01, \*\*\**P* \< .001](JCMM-23-8161-g006){#jcmm14686-fig-0006}

4. DISCUSSION {#jcmm14686-sec-0019}
=============

In the present study, TOE displayed a protective effect on DSS‐induced colitis by improving the severity of clinical symptoms and inflammatory responses. Transcriptome sequencing and GSEA analysis revealed that fatty acid degradation and cytokine‐receptor signalling were implicated in TOE‐treated colitis as compared with the DSS group. RT‐PCR and IHC analysis validated that TOE up‐regulated the expression of Adh5, Aldh3a2 and Acox3, but down‐regulated the expression of CCL20, CXCL5, CCR6 and CXCL1 in DSS‐induced colitis. Gut microbiota analysis showed that TOE promoted the enrichment of S24‐7 and adlercreutzia, but decreased the amount of anaerostipes, enterococcus, enterobacteriaceae and peptostreptococcaceae (Figure [7](#jcmm14686-fig-0007){ref-type="fig"}).

![Schematic representation of the proposed mechanism of TOE on DSS‐induced colitis. DSS destroyed the integrity of mucosal barrier in mice and induced colonic inflammation. But TOE attenuated the clinical symptoms, lowered the inflammatory scoring and inhibited the secretion of pro‐inflammatory factors (TNF‐α, IL‐1β and IL‐6) in DSS‐induced colitis. TOE also increased the expression levels of Adh5, Aldh3a2 and Acox3, but down‐regulated the expression of CCL20, CCR6 and CXCL1/5 in DSS‐induced colitis. In addition, TOE regulated microbial dysbiosis in DSS‐induced colitis](JCMM-23-8161-g007){#jcmm14686-fig-0007}

Acute colitis is a common idiopathic disease characterized by intestinal epithelial barrier damage and inflammatory homoeostasis damage, leading to the secretion of pro‐inflammatory cytokines, such as TNF‐α, IFN‐γ, IL‐1β and IL‐6,[27](#jcmm14686-bib-0027){ref-type="ref"} associated with DSS‐induced colitis.[28](#jcmm14686-bib-0028){ref-type="ref"} Herein, we found that TOE relieved the severity of DSS‐induced colitis and inflammatory infiltration and decreased the production of cytokines TNF‐α, IL‐1β and IL‐6, suggesting that TOE might exhibit an anti‐inflammatory activity in DSS‐induced colitis.

Furthermore, GSEA analysis identified that fatty acid degradation was involved in TOE‐treated colitis. Alcohol dehydrogenase 5 (Adh5), a key enzyme of alcohol dehydrogenase family acts by regulating GSNO, nitric oxide (NO) and RNS.[29](#jcmm14686-bib-0029){ref-type="ref"}, [30](#jcmm14686-bib-0030){ref-type="ref"} Adh5 is involved in smooth muscle relaxation, immune response, inflammation and oncogenesis,[31](#jcmm14686-bib-0031){ref-type="ref"} and alters the cellular homoeostasis.[32](#jcmm14686-bib-0032){ref-type="ref"} Acyl‐CoA oxidase 3 (Acox3), a crosstalk enzyme between alpha‐linolenic acid metabolism and fatty acid metabolism, participates in the desaturation of 2‐methyl branched‐chain fatty acids in peroxisomes and inhibits the progression of cervical cancer.[33](#jcmm14686-bib-0033){ref-type="ref"} Aldehyde dehydrogenase (Aldh) isozymes act in the detoxification of aldehydes. Aldh3a2 can code fatty aldehyde dehydrogenase in mammal,[34](#jcmm14686-bib-0034){ref-type="ref"}, [35](#jcmm14686-bib-0035){ref-type="ref"} and pathogenic variants of Aldh3a2 lead to Sjögren‐Larsson syndrome.[36](#jcmm14686-bib-0036){ref-type="ref"} Herein, we confirmed that TOE exhibited a promoting effect on the fatty acid degradation by increasing Acox3, Adh5 and Aldh3a2 expression in DSS‐induced colitis.

GSEA analysis also identified that cytokine‐receptor signalling was associated with TOE‐treated colitis. CCL20 can be induced by inflammation in endothelial cells, monocytes and dendritic cells,[37](#jcmm14686-bib-0037){ref-type="ref"} and CCL20 and its receptor CCR6 are associated with inflammatory bowel disease (IBD).[38](#jcmm14686-bib-0038){ref-type="ref"}, [39](#jcmm14686-bib-0039){ref-type="ref"} CXC chemokines CXCL1/5 can be produced by colon epithelial cells [40](#jcmm14686-bib-0040){ref-type="ref"}, [41](#jcmm14686-bib-0041){ref-type="ref"} and participate in inflammatory response by recruiting neutrophil in colitis.[42](#jcmm14686-bib-0042){ref-type="ref"} Herein, TOE had the protective effects on DSS‐induced colitis by repressing the production of cytokines CCL20, CXCL1/5 and CCR6.

Gut microbiota is separated from the host compartment by a single layer of epithelial cells in response to the threats from commensals.[43](#jcmm14686-bib-0043){ref-type="ref"}, [44](#jcmm14686-bib-0044){ref-type="ref"} Loss of the intestinal barrier causes the autoimmune and inflammatory diseases,[45](#jcmm14686-bib-0045){ref-type="ref"}, [46](#jcmm14686-bib-0046){ref-type="ref"} and intestinal microbiota enhances the barrier function by promoting the homoeostasis of mucosal immunity.[47](#jcmm14686-bib-0047){ref-type="ref"} The dysbiosis of gut microbiome is associated with the colitis.[48](#jcmm14686-bib-0048){ref-type="ref"}, [49](#jcmm14686-bib-0049){ref-type="ref"}, [50](#jcmm14686-bib-0050){ref-type="ref"}, [51](#jcmm14686-bib-0051){ref-type="ref"} Herein, a 16S rDNA sequencing showed that *S24‐7, adlercreutzia, anaerostipes, enterococcus, enterobacteriaceae* and *peptostreptococcaceae* had a significant difference between TOEH and DSS groups. The enrichment levels of *Bacteroidales S24‐7* and *adlercreutzia* are decreased, but those of *enterobacteriaceae* are increased in IBD.[52](#jcmm14686-bib-0052){ref-type="ref"}, [53](#jcmm14686-bib-0053){ref-type="ref"} *Anaerostipes* can produce butyrate from acetic and lactic acids, which maintains the intestinal barrier and exerts anti‐inflammatory properties.[54](#jcmm14686-bib-0054){ref-type="ref"} Increased abundance of *peptostreptococcaceae* is associated with ulcerative colitis,[55](#jcmm14686-bib-0055){ref-type="ref"} colorectal cancer [56](#jcmm14686-bib-0056){ref-type="ref"} and NAFLD.[57](#jcmm14686-bib-0057){ref-type="ref"} In accordance with these studies, we found that TOE promoted the enrichment of *S24‐7* and *adlercreutzia*, but reduced the amount of *anaerostipes, enterococcus, enterobacteriaceae* and *peptostreptococcaceae*.

In conclusion, our findings demonstrated that TOE attenuated DSS‐induced colitis by regulating fatty acid degradation and microbial dysbiosis, and these findings might provide novel insights into the molecular mechanisms and therapeutic strategies for acute colitis.
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